Purine analogues as antiparasitic agents

Bibliography

• EL KOUNI MH: Potential chemotherapeutic targets in the purine metabolism of parasites. PharmacoL Ther. (2003) 99:283–309.
   PubMed Web of Science ®Google Scholar
• ••Excellent recent review on the subject.
   Google Scholar
• ABRAHAMSEN MS, TEMPLETON TJ,ENOMOTO S et al.: Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science (2004) 304:441–445.
   Google Scholar
• CHAUDHARY K, DARLING JA, FOHL ML et al.: Purine salvage pathways in the Apicomplexan Toxoplasma gondii. J. Biol. Chem. (2004) 279:(30)31221–32227.
   Google Scholar
• ULLMAN B, CARTER D: Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates. Int. J. ParasitoL (1999) 27:(2)203–213.
   Google Scholar
• NAGUIB FN, ILTZSCH MH, EL KOUNI MM, PANZICA RP, EL KOUNI MH: Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii. Biochem PharmacoL (1995) 50:(10)1685-1693.
   Google Scholar
• SOMMER JM, MA H, WANG CC: Cloning, expression and characterization of an unusual guanine phosphoribosyltransferase from Giardia lamblia. Mol. Biochem. ParasitoL (1999) 78:185–193.
   Google Scholar
• SUCHAIL S, SARCIRON MES, PETAVY AF: Purine metabolism in Echinococcus multilocularis. Comp. Biochem. Physiol. (1998) 120B:633–637.
   Google Scholar
• DOYLE PS, KANAANI J, WANG CC: Hypoxanthine, guanine, xanthine phosphoribosyltransferase activity in Cryptosporidium parvum. Exp. ParasitoL (1998)89:9–15.
   PubMedGoogle Scholar
• MUNAGALA NR, WANG CC: Adenosine is the primary precursor of all purine nucleotides in Trichomonas vaginalis. Mol. Biochem. ParasitoL (2003) 127:143–149.
   PubMedGoogle Scholar
• CRAIG SP III, EAKIN EA: Purine salvage enzymes of parasites as targets for structure-based inhibitor design. ParasitoL Today (1997) 13:(6)238–241.
   Google Scholar
• •Concise review focusing primarily on parasitic HGPRT.
   Google Scholar
• STRIEPEN B, KISSINGER JC: Genomics meet transgenics in the elusive Cryptosporidium drug target. Trends ParasitoL (2004) 20:(8)355–358.
   Google Scholar
• •Review explaining the new strategies for finding chemotherapeutic targets, based on genomics.
   Google Scholar
• YADAV V, CHU CK, RAIS RH et al.: Synthesis, biological activity and molecular modelling of 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase. J. Med Chem. (2004) 47:(8)1987–1996.
   Google Scholar
• BZOWSKA A, KULIKOWSKA E, SHUGAR D: Purine nucleoside phosphorylases: properties, functions and clinical aspects. PharmacoL Ther. (2000) 88:349–425.
   PubMed Web of Science ®Google Scholar
• ••Very complete review on the various PNPand their inhibitors.
   Google Scholar
• GHERARDI A. SARCIRON ME, PETAVY AF, PEYRON F: Purine pathway enzymes in a cyst forming strain of Toxoplasma gondii. Life Sci. (1999) 65:(17)1733-1738.
   Google Scholar
• FREITAS DA SILVEIRA NJ, UCHOA HB, CANDURI F et aL: Structural bioinformatics study of PNP from Schistosoma mansoni. Biochem. Biophys. Res. Comm. (2004) 322:100–104.
   PubMedGoogle Scholar
• FURNEAUX RH, SCHRAMM VI,, TYLER PC: Transition state analogue inhibitors of protozoan nucleoside hydrolases. Bioorg. Med. Chem. (1999) 7:(11)2599–2606.
   Google Scholar
• EVANS GB, FURNEAUX RH, GAINSFORD GJ et al.: 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases. J. Med. Chem. (2003) 46:155–160.
   PubMedGoogle Scholar
• SUFFRIN JR, MESHNICK SR, SPIESS AJ, GAROFALO-HANNAN J, PAN XQ, BACCHI CJ: Methionine recycling pathways and antimalarial drug design. Antimicrob. Agents Chemother. (1995) 39:(11)2511–2515.
   Google Scholar
• UMEJIEGO NN, LI C, RIERA T, HEDSTROM L, STRIEPEN B: Cryptosporidium parvum IMP dehydrogenase. Identification of functional, structural, and dynamic properties that can be exploited for drug design./ Biol. Chem. (2004) 279:(39)40320–40327.
   Google Scholar
• CASS CE, YOUNG JD, BALDWIN SA et al.: Nucleoside transporters of mammalian cells. Pharm. BiotechnoL (1999) 12:313–352.
   PubMedGoogle Scholar
• ••Clear review on the complex field of mammalian nucleoside transporters.
   Google Scholar
• CARTER NS, LANDFEAR SM, ULLMAN B: Nucleoside transporters of parasitic protozoa. Trends ParasitoL (2001) 17:142–145.
   PubMed Web of Science ®Google Scholar
• ••Concise review focused on parasiticprotozoa.
   Google Scholar
• DE KONING HP, AL-SALABI MI, COHEN AM, COOMBS GH, WASTLING JM: Identification and characterisation of high affinity nucleoside and nucleobase transporters in Toxoplasma gondii. Int. J. Parasitol (2003) 33:(8)821–831.
   Google Scholar
• SARCIRON ME, LAWTON P, PETAVY AF, PEYRON F: Alterations of Toxoplasma gondii induced by 2',3'-dideoxyinosine in vitro. J. Parasitol (1998) 84:1055–1059.
   PubMed Web of Science ®Google Scholar
• SARCIRON ME, LAWTON P, SACCHARIN C, PETAVY AF, PEYRON F: Effects of 2',3'-Dideoxyinosine on Toxoplasma gondii cysts in mice. Antimicrob. Agents Chemother. (1997) 41:1531–1536.
   PubMedGoogle Scholar
• LAWTON P, HEJL C, MANCASSOLA R, NACIRI M, PETAVY AF: Effects of purine nucleosides on the in vitro growth of Cryptosporidium parvum. FEMS Microbiol Lett. (2003) 226:39–43.
   PubMedGoogle Scholar
• BALAICIA-FOUCE R, REGUERA RM, CUBRIA JC, ORDOEZ D: The pharmacology of leishmaniasis. Gen. Pharmacol (1998) 30:(4)435–443.
   Google Scholar
• LEE H, HANES J, JOHNSON KA: Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry (2003) 42:(50)14711–14719.
   Google Scholar
• BOTROS S, WILLIAM S, HAMMAM 0, ZIDEK Z, HOLY A: Activity of 9-(S)43-hydroxy-2- (phosphonomethoxy)propyll adenine against schistosomiasis mansoni in mice. Antimicrob. Agents Chemother. (2003) 47:(12)3853–3858.
   Google Scholar
• DREW ME, MORRIS JC, WANG Z et al: The adenosine analog tubercidin inhibits glycolysis in Trypanosoma brucei as revealed by an RNA interference library. J. Biol Chem. (2003) 278:(47)46596–46600.
   Google Scholar
• PFEFFERKORN ER, BZIK DJ, HONSINGER CP: Toxop/asma gondii: mechanism of the parasitostatic action of 6-thioxanthine. Exp. Parasitol (2001) 99:235–243.
   PubMedGoogle Scholar
• SCHRAMM VL: Immucillins as antibioticsfor T-cell proliferation and malaria. Nucleosides Nucleotides Nucleic acids (2004) 23:(8–9)1305-1311. Excellent review about the dual chemotherapeutic potential of immucillins.
   Google Scholar
• SCHRAMM VL: Enzymatic transitionstates: thermodynamics, dynamics and analogue design. Arch. Biochem. Biophys. (2005) 433:13-26. Excellent summary of the rationale of transition-state inhibitor design and synthesis.
   Google Scholar
• LAWTON P, HEJL C, SARCIRON ME, MANCASSOLA R, NACIRI M, PETAVY AF: Use of a non-adherent cell culture system for testing the effect of 2',3'-dideoxyinosine against Cryptosporidium parvum. FEMS Microbiol Lett. (1999) 176:235–240.
   Google Scholar
• KICSKA GA, TYLER PC, EVANS GB, FURNEAUX RH, SCHRAMM VI,, KIM K: Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase. j Biol Chem. (2002) 277:(5)3226–3231.
   Google Scholar
• TING LM, SHI W, LEWANDOWICZ A et al.: Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins. j Biol. Chem. (2005) 280:(10)9547–9554.
   Google Scholar
• BORROTO-ESODA K, MYRICK F, FENG J, JEFFREY J, FURMAN P: In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus Type 1. Antimicrob. Agents Chemother. (2004) 48:(11)4387–4394.
   Google Scholar